Literature DB >> 7326201

Biochemical effects of vindesine.

W A Creasey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326201      PMCID: PMC2010863          DOI: 10.1038/bjc.1981.293

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.

Authors:  K E MOORE; E W LARIVIERE
Journal:  Biochem Pharmacol       Date:  1963-11       Impact factor: 5.858

2.  Biochemical effects of d-tetrandrine and thalicarpine.

Authors:  W A Creasey
Journal:  Biochem Pharmacol       Date:  1976-08-15       Impact factor: 5.858

3.  Pharmacokinetics of vindesine and vincristine in humans.

Authors:  R J Owellen; M A Root; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  Effects of adriamycin on surface properties of sarcoma 180 ascites cells.

Authors:  S A Murphree; L S Cunningham; K M Hwang; A C Sartorelli
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

5.  [The effect of vincaleukoblastine (Velbe) on the glycolysis of tumor cells].

Authors:  P Obrecht; N E Fusenig
Journal:  Eur J Cancer       Date:  1966-06       Impact factor: 9.162

6.  Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.

Authors:  W A Creasey
Journal:  Biochem Pharmacol       Date:  1969-01       Impact factor: 5.858

7.  Biochemical effects of the vinca alkaloids. 3. The synthesis of ribonucleic acid and the incorporation of amino acids in Ehrlich ascites cells in vitro.

Authors:  W A Creasey; M E Markiw
Journal:  Biochim Biophys Acta       Date:  1965-08-10

8.  Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.

Authors:  R J Owellen; C A Hartke; R M Dickerson; F O Hains
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

Review 9.  Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).

Authors:  R W Dyke; R L Nelson
Journal:  Cancer Treat Rev       Date:  1977-06       Impact factor: 12.111

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.